Announcement
Genezen Appoints Mike Wourms as Chief Operations Officer
Genezen
PR-10-24-NI-36Oct 08, 2024
Anniversary
Alconox Inc. Announced Its 75th Anniversary as an Internationally Distributed Manufacturer of Critical Cleaning Detergents
Alconox Inc.
PR-M06-21-017Jun 09, 2021
Clinical Trial Services
CVS Health Introduces Clinical Trial Services
CVS Health
PR-M05-21-016-981May 21, 2021
CPhI China
Opportunities Abound in China’s Pharmaceutical Market
CPhI & P-MEC China
PAP-Q1-20-CL-024Mar 19, 2020
Coronavirus
INTERPHEX Postponed Due to COVID-19
INTERPHEX
PR-M03-20-NI-012Mar 10, 2020
M&A
Lilly Announces Agreement to Acquire Dermira
Eli Lilly and Company
PR-M01-20-NI-032Jan 21, 2020
Bankruptcy
Melinta Therapeutics Announces Restructuring and Files Bankruptcy
Melinta Therapeutics
PR-M01-20-NI-008Jan 03, 2020
Restructuring
Halozyme Announces Actions To Focus Strategy On ENHANZE® Drug Delivery Technology
Halozyme Therapeutics
PR-M11-19-NI-009-1975Nov 08, 2019
Portfolio Update
Syros Announces Update on Selective CDK7 Inhibitor Portfolio
Syros Pharmaceuticals
PR-M10-19-NI-026Oct 17, 2019
Expansion
TriPharm Services Announces Creation of Pharmaceutical Manufacturing Center
Nice Insight
PR-M10-19-NI-028Oct 17, 2019
Leadership
Ian Read to Retire as Executive Chairman of Pfizer’s Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman
Pfizer
PR-M09-19-NI-053Sep 27, 2019
Opening
GENEWIZ Celebrates Opening of European Headquarters in Germany
GENEWIZ
PR-M09-19-NI-052Sep 26, 2019
Leadership
Alkermes Announces the Appointment of Board of Directors
Alkermes
PA2111Sep 18, 2019
Microbial
Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio
Charles River
PR-M09-19-NI-039-2117Sep 16, 2019
M&A
Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK
Avalon Ventures
PR-M09-19-NI-034Sep 13, 2019
Clinical Progress
Sage Therapeutics Announces Clinical Updates and Progress Across Neuroscience Pipeline During “Sage FutureCast”
Sage Therapeutics
PR-M07-19-NI-067Jul 25, 2019
Anniversary
Northway Biotechpharma Celebrates 15 Years of Growth and Success
Northway Biotechpharma
PR-M07-19-NI-057-2360Jul 18, 2019
Financing
IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline
IGM Biosciences, Inc.
PR-M07-19-NI-028Jul 11, 2019
Leadership
Xencor Announces the Planned Retirement of Chief Medical Officer Paul Foster, M.D.
Xencor, Inc.
PR-M07-19-NI-006-2425Jul 03, 2019
Operational Review
ImmunoGen Announces Completion of Operational Review
ImmunoGen
PR-M07-19-NI-005-2432Jul 02, 2019